US20130150882A1 - Apparatus and method for diverting embolic material - Google Patents
Apparatus and method for diverting embolic material Download PDFInfo
- Publication number
- US20130150882A1 US20130150882A1 US13/536,954 US201213536954A US2013150882A1 US 20130150882 A1 US20130150882 A1 US 20130150882A1 US 201213536954 A US201213536954 A US 201213536954A US 2013150882 A1 US2013150882 A1 US 2013150882A1
- Authority
- US
- United States
- Prior art keywords
- anchor
- aortic arch
- deflection device
- elongate member
- aorta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000463 material Substances 0.000 title claims abstract description 18
- 230000003073 embolic effect Effects 0.000 title claims abstract description 10
- 238000000034 method Methods 0.000 title claims abstract description 5
- 210000002376 aorta thoracic Anatomy 0.000 claims abstract description 26
- 210000000709 aorta Anatomy 0.000 claims abstract description 22
- 230000017531 blood circulation Effects 0.000 description 15
- 239000002245 particle Substances 0.000 description 8
- 230000004888 barrier function Effects 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 3
- 229910001000 nickel titanium Inorganic materials 0.000 description 3
- 230000009424 thromboembolic effect Effects 0.000 description 3
- 230000001133 acceleration Effects 0.000 description 2
- 230000002965 anti-thrombogenic effect Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920000431 shape-memory polymer Polymers 0.000 description 2
- 229920004934 Dacron® Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 239000002977 biomimetic material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229920003223 poly(pyromellitimide-1,4-diphenyl ether) Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/12036—Type of occlusion partial occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/068—Modifying the blood flow model, e.g. by diffuser or deflector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0017—Angular shapes
- A61F2230/0019—Angular shapes rectangular
Definitions
- the human aorta includes an ascending portion and a descending portion, and one or more arch vessels communicating with the aorta for directing blood flow to the brain of the patient.
- U.S. Patent Application 2008/0140110 (the “110 application”, which is incorporated herein by reference), entitled Implant, Systems and Methods for Physically Diverting Material in Blood Flow Away from the Head, describes a device for preventing stroke due to embolic material in the bloodstream of a patient.
- the device includes a physical deflector element configured for at least partial placement in the aorta of the patient and a mounting structure coupled to the physical deflector element.
- the mounting structure is configured to engage at least one of the aorta or an arch vessel communicating with the aorta.
- the physical deflector element is constructed and arranged to direct blood flow in the aorta in a manner that directs embolic material in the blood flow past the one or more arch vessels and into the descending portion of the aorta.
- the present application describes alternatives to the devices disclosed in the '110 application.
- FIGS. 1 and 2 schematically show a first embodiment of a thromboembolic diverter positioned in an aorta
- FIG. 3 is a perspective view of the diverter of FIG. 1 ;
- FIG. 4 is a side elevation view of the diverter of FIG. 1 ;
- FIG. 5 is a perspective view of an alternate thromboembolic diverter
- FIG. 6 schematically shows the diverter of FIG. 5 positioned in an aorta
- FIGS. 7A-7B are a sequence of drawings schematically illustrating removal of the diverter of FIG. 1 from the aorta;
- FIGS. 8A through 10 B show alternative diverter designs.
- FIG. 1 shows a first embodiment of a thromboembolic diverter 10 positioned within the aortic arch.
- Diverter 10 includes an anchor 12 and a deflector 14 .
- Anchor 12 is positioned within an arch vessel such as the brachiocephalic artery as shown.
- Anchor 12 may be a tubular member that is deliverable into the arch vessel in a radially compressed state, and is expandable into contact with the arch vessel walls once in the desired position. Expansion may be carried out using a separate device positioned within the anchor, such as a balloon, or the anchor may be self-expandable.
- the deflector 14 is coupled to the portion of the anchor 12 that is closest to the aorta.
- the deflector includes an elongate member 16 that extends within the aortic arch, below the ostia of one or more of the arch vessels. In the illustrated embodiment, the member 16 extends beneath all three of the ostia, although in other embodiments it extends beneath just one or two of the ostia.
- the Member 16 includes a first surface facing the ostia, and a second surface that is opposite from the first surface.
- the deflector 14 is preferably contoured such that the first and second surfaces curve generally in parallel to the contour of the aortic arch such that a channel of generally uniform cross-section is formed along the second surface (between the first surface and the opposing walls of the aortic arch), and another channel (preferably also of generally uniform cross-section) is formed along the first surface—between the first surface and the opposing walls of the aortic arch.
- the long edges of the member 16 may extend laterally into contact with the walls of the aorta, or the member 16 may be narrower than the corresponding diameter of the aorta so that some blood can pass between the long edges and the adjacent walls of the aorta.
- the diverter 10 includes a barrier region 22 disposed within the aortic arch, upstream of the ostia of the arch vessel within which the anchor 12 is positioned.
- one end of the anchor 12 extends into the aorta and its upstream-facing portion forms this surface.
- the barrier region 22 may be part of the deflector 14 or a transition section of the diverter 10 in the region where the deflector and anchor 12 are coupled together.
- Downstream of the barrier is an entrance 24 for passage of blood into the ostium within which the anchor 12 is positioned.
- the entrance may be an orifice or an opening in the diverter 10 .
- the diverter 10 may be constructed in a variety of ways.
- the anchor 12 may have a stent-like construction formed using a tubular shape memory device constructed of nitinol, shape memory polymer, or other suitable materials.
- the device anchor and/or deflector
- the anchor may be of a woven construction or formed from laser cut tubing.
- the anchor may include features that give some structural stability to cause the anchor to radially support the device against a vessel wall.
- a mesh, band or other framework formed of shape memory (e.g. nickel titanium alloy, nitinol or shape memory polymer) elements or stainless steel, Eligoy, or MP35N wires or structures may be used.
- the anchor may include a smooth polymeric barrier that is both anti-proliferative and anti-thrombogenic and that thereby prevents endothelial growth and thrombus formation on the anchor.
- materials for the polymeric barrier include, but are not limited to ePTFE, or other fluoropolymers, silicone, non-woven nylon, or biomimetic materials.
- the deflector 14 may include an outer frame defining the edges of the deflector, with the elongate member 16 disposed within the outer frame.
- the elongate member 16 may be formed of a variety of materials, such as silicone, ePTFE, polyurethane, kapton, or dacron or other woven material.
- the elongate member preferably includes a surface or coating of anti-thrombogenic material such as heparin.
- the elongate member deflects the particles away from the branch vessels, and creates or enhances a laminar flow L of blood within the aortic arch which can carry particles away from the branch vessels and downstream into the descending aorta, and/or facilitate acceleration of particles away from the blood flow entrance towards, the descending aorta.
- blood may flow around the elongate member as shown, and into the branch vessels.
- FIGS. 3 and 4 show one variation of the FIG. 1 diverter, in which the anchor 12 and deflector 14 are integral pieces formed from a single laser cut tube.
- the portion of the tube that will become the deflector is cut to form an elongate support 26 , which preferably has a tapered distal- or upstream-end (i.e. the end furthest from the anchor).
- the support 26 may take the form of a frame defining an open area, or it may have other configurations.
- the support 26 is shape set to give the frame the curvature shown.
- the open area(s) surrounded by the frame or otherwise defined by the support are filled or covered by a material such as polyurethane, silicone, or other material that will prevent passage of emboli through the frame.
- the covering may be applied by dipping the frame in the material that is to form the elongate member.
- FIGS. 5 and 6 show an alternative to the FIG. 3 diverter, in which the anchor 12 and deflector 14 are arranged such that the anchor 12 is engaged with the walls of the aorta (in this embodiment upstream of the brachiocephalic artery).
- this embodiment may be formed from a single tube, laser cut to form the anchor and a frame for the deflector, then shape-set if needed to shape the deflector. A covering is then applied to the support as discussed above.
- FIG. 6 illustrates positioning of the diverter and use of the diverter to deflect particles away from the ostia to the carotid and brachiocephalic arteries, causing the particles to continue to move downstream rather than passing into the head vessels.
- FIGS. 7A-7C are a sequence of views illustrating use of a cutting device to detach the deflector from the anchor in an embodiment such as those shown in FIGS. 1-6 .
- a cutting tool 18 having a snare 20 on it is advanced into the aorta (such as via the descending aorta as shown in FIG. 7A ) and positioned with the snare loop over the deflector 14 .
- the snare loop is advanced to the base of the anchor as shown.
- a retrieval catheter 22 is advanced over the deflector 14 , preferably up to the snare loop.
- the snare loop is used to cut the deflector from the anchor 12 .
- the retrieval catheter 22 is withdrawn (with the severed deflector within it as shown in FIG. 7C ), leaving only the anchor 12 behind. This method of removing the deflector minimizes trauma to the vessel within which the anchor is seated by leaving the anchor in place. In other extraction methods, both the anchor and the deflector may be removed as a single piece or as separate pieces.
- FIG. 5 and related figures of the '110 application illustrate embodiments of individual tubular deflector elements that may be inserted and mounted within the entrances to the arch vessels (e.g. brachiocephalic, carotid) extending from the aortic arch.
- Each of the disclosed tubular elements includes a blood flow entrance and a blood flow exit end. The exit end of each tube extends within the respective arch vessel, while the entrance end extends within the aorta.
- a bend in the tube locates the entrance end a suitable or desired distance downstream in the aorta such that particles will tend to be deflected by the tubular member and continue within the blood flow as opposed to reversing direction and entering the entrance end of one of the tubes.
- FIGS. 8A through 8D illustrate alternative shapes to the tubes shown in the '110 application, which may be made of silicone or other polymeric material anchored within the arch vessel.
- the deflector element includes a first portion 30 of tubing (shown as generally vertical in the drawings) that defines the blood flow exit 32 (which is anchored within an arch vessel) and a second portion 34 of tubing extending laterally from the first portion (and shown as generally horizontal in the drawings) which defines the blood flow entrance 36 (which is disposed in the aortic arch).
- FIGS. 8A and 8B illustrate embodiments in which, the second portion 34 has a length that is equal in length or longer than the length of the first portion 30 ( FIG. 8A ), or is shorter than the length of first portion 30 ( FIG.
- the second portion 34 tapers to a narrower diameter at its distal end.
- the second portion 34 includes a plurality (four shown) of baffles 38 extending radially from the outer surface of the tubing.
- FIGS. 9A through 9F show alternatives to the FIG. 8 embodiments.
- Each of these embodiments includes a tubular device 40 made of silicone or other polymeric material anchored within the arch vessel.
- At one end of the tube is an exit opening 42 disposed within the arch vessel.
- the opposite end 44 of the tube is closed.
- a blood flow entrance 46 in the tubular device comprises an opening formed in a downstream wall of the tube.
- the exit opening 42 is disposed within the arch vessel, and the entrance opening 46 is disposed in a downstream-facing direction within the aortic arch.
- the entrance 46 is adjacent to the lower end 44 of the tube, whereas in the FIG. 9B embodiment the entrance 46 is positioned further up the tubular wall, closer to the exit opening 42 .
- FIG. 9A the entrance 46 is adjacent to the lower end 44 of the tube, whereas in the FIG. 9B embodiment the entrance 46 is positioned further up the tubular wall, closer to the exit opening 42 .
- FIGS. 9C-9F embodiments incorporate elements designed to encourage laminar flow of blood within the aortic arch and/or to facilitate acceleration of particles away from the blood flow entrance.
- an upstream element 48 which may be a wedge shaped element positioned with the narrow end of the wedge extending upstream.
- FIGS. 9D and 9E show use of a pair of wedge-shaped downstream elements 50 positioned on opposite sides of the entrance opening 46 , with the narrow end of each wedge extending downstream.
- FIGS. 10A and 10B are similar to the FIG. 8B and FIG. 9B embodiments, respectively, but comprises an expandable stent-like anchor 12 disposed within the blood flow exit opening of the tubular device.
- the anchor and tube may be implanted separately or as a singular piece.
- the device is positioned with the blood flow exit opening within a branch vessel, in proximity to the ostia at the aortic arch, and with the entrance opening disposed within the aortic arch.
- the stent-like anchor 12 is delivered through the lumen of the device (e.g. carried in a compressed position within a deployment sheath or catheter) and expanded, such that expansion of the stent-like anchor within the arch vessel causes the upper end of the tubular device to be engaged between the expanded anchor and the surrounding vessel wall.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Prostheses (AREA)
Abstract
An embolic deflection device includes an anchor engageable with a lumen of a branch vessel extending from an aortic arch and a deflection device, the deflection device having a first end coupled to the anchor and an elongate member extending from the deflection device. A method of deflecting embolic material away from a branch vessel extending from an aortic arch includes providing a deflection device comprising a anchor and an elongate member extending from the anchor. The anchor is engaged with a lumen of the branch vessel and positioned such that the elongate member extends within the aortic arch in proximity to ostia of at least two branch vessels. Embolic material flowing from the ascending aorta to the aortic arch is diverted by the elongate member away from the branch vessels and into the descending aorta.
Description
- This application claims the benefit of U.S. Provisional Application No. 61/501,771, filed 28 Jun. 2011, which is incorporated herein by reference.
- The human aorta includes an ascending portion and a descending portion, and one or more arch vessels communicating with the aorta for directing blood flow to the brain of the patient. U.S. Patent Application 2008/0140110 (the “110 application”, which is incorporated herein by reference), entitled Implant, Systems and Methods for Physically Diverting Material in Blood Flow Away from the Head, describes a device for preventing stroke due to embolic material in the bloodstream of a patient. The device includes a physical deflector element configured for at least partial placement in the aorta of the patient and a mounting structure coupled to the physical deflector element. The mounting structure is configured to engage at least one of the aorta or an arch vessel communicating with the aorta. The physical deflector element is constructed and arranged to direct blood flow in the aorta in a manner that directs embolic material in the blood flow past the one or more arch vessels and into the descending portion of the aorta.
- The present application describes alternatives to the devices disclosed in the '110 application.
-
FIGS. 1 and 2 schematically show a first embodiment of a thromboembolic diverter positioned in an aorta; -
FIG. 3 is a perspective view of the diverter ofFIG. 1 ; -
FIG. 4 is a side elevation view of the diverter ofFIG. 1 ; -
FIG. 5 is a perspective view of an alternate thromboembolic diverter; -
FIG. 6 schematically shows the diverter ofFIG. 5 positioned in an aorta; -
FIGS. 7A-7B are a sequence of drawings schematically illustrating removal of the diverter ofFIG. 1 from the aorta; -
FIGS. 8A through 10 B show alternative diverter designs. -
FIG. 1 shows a first embodiment of athromboembolic diverter 10 positioned within the aortic arch.Diverter 10 includes ananchor 12 and adeflector 14. - The
anchor 12 is positioned within an arch vessel such as the brachiocephalic artery as shown.Anchor 12 may be a tubular member that is deliverable into the arch vessel in a radially compressed state, and is expandable into contact with the arch vessel walls once in the desired position. Expansion may be carried out using a separate device positioned within the anchor, such as a balloon, or the anchor may be self-expandable. - The
deflector 14 is coupled to the portion of theanchor 12 that is closest to the aorta. The deflector includes an elongate member 16 that extends within the aortic arch, below the ostia of one or more of the arch vessels. In the illustrated embodiment, the member 16 extends beneath all three of the ostia, although in other embodiments it extends beneath just one or two of the ostia. - Member 16 includes a first surface facing the ostia, and a second surface that is opposite from the first surface. The
deflector 14 is preferably contoured such that the first and second surfaces curve generally in parallel to the contour of the aortic arch such that a channel of generally uniform cross-section is formed along the second surface (between the first surface and the opposing walls of the aortic arch), and another channel (preferably also of generally uniform cross-section) is formed along the first surface—between the first surface and the opposing walls of the aortic arch. The long edges of the member 16 may extend laterally into contact with the walls of the aorta, or the member 16 may be narrower than the corresponding diameter of the aorta so that some blood can pass between the long edges and the adjacent walls of the aorta. - The
diverter 10 includes abarrier region 22 disposed within the aortic arch, upstream of the ostia of the arch vessel within which theanchor 12 is positioned. In the illustrated embodiment, one end of theanchor 12 extends into the aorta and its upstream-facing portion forms this surface. In other embodiments, thebarrier region 22 may be part of thedeflector 14 or a transition section of thediverter 10 in the region where the deflector andanchor 12 are coupled together. Downstream of the barrier is anentrance 24 for passage of blood into the ostium within which theanchor 12 is positioned. The entrance may be an orifice or an opening in thediverter 10. - The
diverter 10 may be constructed in a variety of ways. For example, theanchor 12 may have a stent-like construction formed using a tubular shape memory device constructed of nitinol, shape memory polymer, or other suitable materials. The device (anchor and/or deflector) may be of a woven construction or formed from laser cut tubing. The anchor may include features that give some structural stability to cause the anchor to radially support the device against a vessel wall. For example, a mesh, band or other framework formed of shape memory (e.g. nickel titanium alloy, nitinol or shape memory polymer) elements or stainless steel, Eligoy, or MP35N wires or structures may be used. The anchor may include a smooth polymeric barrier that is both anti-proliferative and anti-thrombogenic and that thereby prevents endothelial growth and thrombus formation on the anchor. Examples of materials for the polymeric barrier include, but are not limited to ePTFE, or other fluoropolymers, silicone, non-woven nylon, or biomimetic materials. Thedeflector 14 may include an outer frame defining the edges of the deflector, with the elongate member 16 disposed within the outer frame. The elongate member 16 may be formed of a variety of materials, such as silicone, ePTFE, polyurethane, kapton, or dacron or other woven material. The elongate member preferably includes a surface or coating of anti-thrombogenic material such as heparin. - As illustrated in
FIG. 1 , when embolic particles are carried by blood flow into the aorta, the elongate member deflects the particles away from the branch vessels, and creates or enhances a laminar flow L of blood within the aortic arch which can carry particles away from the branch vessels and downstream into the descending aorta, and/or facilitate acceleration of particles away from the blood flow entrance towards, the descending aorta. In either case, blood may flow around the elongate member as shown, and into the branch vessels. -
FIGS. 3 and 4 show one variation of theFIG. 1 diverter, in which theanchor 12 anddeflector 14 are integral pieces formed from a single laser cut tube. In this embodiment, the portion of the tube that will become the deflector is cut to form anelongate support 26, which preferably has a tapered distal- or upstream-end (i.e. the end furthest from the anchor). Thesupport 26 may take the form of a frame defining an open area, or it may have other configurations. Thesupport 26 is shape set to give the frame the curvature shown. The open area(s) surrounded by the frame or otherwise defined by the support are filled or covered by a material such as polyurethane, silicone, or other material that will prevent passage of emboli through the frame. In one embodiment, the covering may be applied by dipping the frame in the material that is to form the elongate member. -
FIGS. 5 and 6 show an alternative to theFIG. 3 diverter, in which theanchor 12 anddeflector 14 are arranged such that theanchor 12 is engaged with the walls of the aorta (in this embodiment upstream of the brachiocephalic artery). As with the prior embodiment, this embodiment may be formed from a single tube, laser cut to form the anchor and a frame for the deflector, then shape-set if needed to shape the deflector. A covering is then applied to the support as discussed above.FIG. 6 illustrates positioning of the diverter and use of the diverter to deflect particles away from the ostia to the carotid and brachiocephalic arteries, causing the particles to continue to move downstream rather than passing into the head vessels. -
FIGS. 7A-7C are a sequence of views illustrating use of a cutting device to detach the deflector from the anchor in an embodiment such as those shown inFIGS. 1-6 . Acutting tool 18 having asnare 20 on it is advanced into the aorta (such as via the descending aorta as shown inFIG. 7A ) and positioned with the snare loop over thedeflector 14. The snare loop is advanced to the base of the anchor as shown. Referring toFIG. 7B , aretrieval catheter 22 is advanced over thedeflector 14, preferably up to the snare loop. The snare loop is used to cut the deflector from theanchor 12. Theretrieval catheter 22 is withdrawn (with the severed deflector within it as shown inFIG. 7C ), leaving only theanchor 12 behind. This method of removing the deflector minimizes trauma to the vessel within which the anchor is seated by leaving the anchor in place. In other extraction methods, both the anchor and the deflector may be removed as a single piece or as separate pieces. -
FIG. 5 and related figures of the '110 application illustrate embodiments of individual tubular deflector elements that may be inserted and mounted within the entrances to the arch vessels (e.g. brachiocephalic, carotid) extending from the aortic arch. Each of the disclosed tubular elements includes a blood flow entrance and a blood flow exit end. The exit end of each tube extends within the respective arch vessel, while the entrance end extends within the aorta. A bend in the tube locates the entrance end a suitable or desired distance downstream in the aorta such that particles will tend to be deflected by the tubular member and continue within the blood flow as opposed to reversing direction and entering the entrance end of one of the tubes. -
FIGS. 8A through 8D illustrate alternative shapes to the tubes shown in the '110 application, which may be made of silicone or other polymeric material anchored within the arch vessel. In these embodiments, the deflector element includes a first portion 30 of tubing (shown as generally vertical in the drawings) that defines the blood flow exit 32 (which is anchored within an arch vessel) and a second portion 34 of tubing extending laterally from the first portion (and shown as generally horizontal in the drawings) which defines the blood flow entrance 36 (which is disposed in the aortic arch).FIGS. 8A and 8B illustrate embodiments in which, the second portion 34 has a length that is equal in length or longer than the length of the first portion 30 (FIG. 8A ), or is shorter than the length of first portion 30 (FIG. 8B ). InFIG. 8C , the second portion 34 tapers to a narrower diameter at its distal end. InFIG. 8D , the second portion 34 includes a plurality (four shown) of baffles 38 extending radially from the outer surface of the tubing. -
FIGS. 9A through 9F show alternatives to theFIG. 8 embodiments. Each of these embodiments includes atubular device 40 made of silicone or other polymeric material anchored within the arch vessel. At one end of the tube is anexit opening 42 disposed within the arch vessel. Theopposite end 44 of the tube is closed. Ablood flow entrance 46 in the tubular device comprises an opening formed in a downstream wall of the tube. In these embodiments, theexit opening 42 is disposed within the arch vessel, and theentrance opening 46 is disposed in a downstream-facing direction within the aortic arch. In theFIG. 9A embodiment, theentrance 46 is adjacent to thelower end 44 of the tube, whereas in theFIG. 9B embodiment theentrance 46 is positioned further up the tubular wall, closer to theexit opening 42. TheFIG. 9C-9F embodiments incorporate elements designed to encourage laminar flow of blood within the aortic arch and/or to facilitate acceleration of particles away from the blood flow entrance. InFIGS. 9C , 9D and 9F, anupstream element 48 which may be a wedge shaped element positioned with the narrow end of the wedge extending upstream.FIGS. 9D and 9E show use of a pair of wedge-shapeddownstream elements 50 positioned on opposite sides of theentrance opening 46, with the narrow end of each wedge extending downstream. -
FIGS. 10A and 10B are similar to theFIG. 8B andFIG. 9B embodiments, respectively, but comprises an expandable stent-like anchor 12 disposed within the blood flow exit opening of the tubular device. The anchor and tube may be implanted separately or as a singular piece. For example, the device is positioned with the blood flow exit opening within a branch vessel, in proximity to the ostia at the aortic arch, and with the entrance opening disposed within the aortic arch. Once the device is positioned, the stent-like anchor 12 is delivered through the lumen of the device (e.g. carried in a compressed position within a deployment sheath or catheter) and expanded, such that expansion of the stent-like anchor within the arch vessel causes the upper end of the tubular device to be engaged between the expanded anchor and the surrounding vessel wall.
Claims (2)
1. An embolic deflection device, comprising:
an anchor engageable with a lumen of a branch vessel extending from an aortic arch; and
a deflection device, the deflection device having a first end coupled to the anchor and an elongate member extending from the deflection device.
2. A method of deflecting embolic material away from a branch vessel extending from an aortic arch, comprising:
providing a deflection device comprising a anchor and an elongate member extending from the anchor;
engaging the anchor with a lumen of the branch vessel and positioning the elongate member to extend within the aortic arch in proximity to ostia of at least two branch vessels, wherein embolic material flowing from the ascending aorta to the aortic arch is diverted by the elongate member away from the branch vessels and into the descending aorta.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/536,954 US20130150882A1 (en) | 2011-06-28 | 2012-06-28 | Apparatus and method for diverting embolic material |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161501771P | 2011-06-28 | 2011-06-28 | |
US13/536,954 US20130150882A1 (en) | 2011-06-28 | 2012-06-28 | Apparatus and method for diverting embolic material |
Publications (1)
Publication Number | Publication Date |
---|---|
US20130150882A1 true US20130150882A1 (en) | 2013-06-13 |
Family
ID=48572697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/536,954 Abandoned US20130150882A1 (en) | 2011-06-28 | 2012-06-28 | Apparatus and method for diverting embolic material |
Country Status (1)
Country | Link |
---|---|
US (1) | US20130150882A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120046685A1 (en) * | 2005-06-10 | 2012-02-23 | S.M.T. Research And Development Ltd. | Implant device particularly useful for implantation in the intravascular system for diverting emboli |
WO2015173646A1 (en) * | 2014-05-16 | 2015-11-19 | Veosource Sa | Implantable self-cleaning blood filters |
US9668849B2 (en) | 2001-12-05 | 2017-06-06 | Keystone Heart Ltd. | Endovascular device for entrapment of participate matter and method for use |
-
2012
- 2012-06-28 US US13/536,954 patent/US20130150882A1/en not_active Abandoned
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9668849B2 (en) | 2001-12-05 | 2017-06-06 | Keystone Heart Ltd. | Endovascular device for entrapment of participate matter and method for use |
US10624732B2 (en) | 2001-12-05 | 2020-04-21 | Keystone Heart Ltd. | Endovascular device for entrapment of participate matter and method for use |
US20120046685A1 (en) * | 2005-06-10 | 2012-02-23 | S.M.T. Research And Development Ltd. | Implant device particularly useful for implantation in the intravascular system for diverting emboli |
US20150182324A1 (en) * | 2005-06-10 | 2015-07-02 | Keystone Heart Ltd. | Implant device particularly useful for implantation in the intravascular system for diverting emboli |
WO2015173646A1 (en) * | 2014-05-16 | 2015-11-19 | Veosource Sa | Implantable self-cleaning blood filters |
US10213287B2 (en) | 2014-05-16 | 2019-02-26 | Veosource Sa | Implantable self-cleaning blood filters |
EP3718506A1 (en) * | 2014-05-16 | 2020-10-07 | Veosource SA | Implantable self-cleaning blood filters |
US10925707B2 (en) | 2014-05-16 | 2021-02-23 | Veosource Sa | Implantable self-cleaning blood filters |
US10966811B2 (en) | 2014-05-16 | 2021-04-06 | Veosource Sa | Implantable self-cleaning blood filters |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210282948A1 (en) | Vessel Prosthesis | |
EP1888006B1 (en) | Flexible stent-graft | |
US20150182324A1 (en) | Implant device particularly useful for implantation in the intravascular system for diverting emboli | |
US6866680B2 (en) | Implantable stroke preventing device | |
US7329269B2 (en) | Intravascular filtering devices and methods | |
US7060082B2 (en) | Perfusion guidewire in combination with a distal filter | |
US20080140110A1 (en) | Implant, systems and methods for physically diverting material in blood flow away from the head | |
US10828040B2 (en) | Vascular implant | |
CA2593817A1 (en) | Stent retrieval member and devices and methods for retrieving or repositioning a stent | |
CN103237526A (en) | Vascular remodeling device | |
CN111134899A (en) | Aortic implant | |
US20070129791A1 (en) | Stent with integral filter | |
US20150257868A1 (en) | Interlaced particulate filter | |
US20130150882A1 (en) | Apparatus and method for diverting embolic material | |
US20180036111A1 (en) | Luminal endoprosthesis | |
WO2012158881A1 (en) | Vascular remodeling device | |
US20130211498A1 (en) | Endoprosthesis with varying compressibility and methods of use | |
US20220401239A1 (en) | Endovascular apparatus with enhanced retrievability and related methods | |
WO2007067886A2 (en) | Stents with beveled ends and methods of use thereof | |
CN111658224B (en) | Recoverable vena cava filter | |
US20120259399A1 (en) | Intraluminal scaffold system and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- INCOMPLETE APPLICATION (PRE-EXAMINATION) |